### Study of Acute Coronary Syndromes with Percutaneous Coronary Intervention and optimal antiplatelet therapy
* Identify Cohort


Identify patients with Acute Coronary Syndrome (ICD 10 -  I21 Acute myocardial infarction; I20-I25  Ischemic heart diseases; I24  Other acute ischemic heart diseases) https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.114.302737

* Identify condition under study

Of those identify those who have percutaneous coronary intervention (ICD-10 PCS 02703ZZ plus p. 2-8 AHRQ defined codes)
Of those identify those on ticagrelor, prasugrel or clopidogrel and other antiplatelets

* Identify concomitant medications

Of those collect concomitant medications from the same period (1 month prior to event to 18 months post event)

* Retrieve study data points

Collect age, medical history,
And from those we could either retrieve:
Of those, collect any events - death, stroke, myocardial infarction, hospitalization (Major Adverse Cardiovascular Events) and major bleeding events (defined as bleeding requiring 2 units of packed red blood cells)

* Example Study

Example study ClinicalTrials.gov Identifier: NCT02190123 others - entire query
